Foslinanib ( TRX-818;TRX818 )

Catalog No. M11045 CAS No. 1256037-60-1

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Foslinanib
Note

Research use only, not for human use.
Brief Description

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
Description

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.Liver Cancer Phase 2 Clinical
Synonyms

TRX-818;TRX818
Pathway

Others
Target

Other Targets
Recptor

Other Targets
Research Area

Cancer
Indication

Liver Cancer

CAS Number

1256037-60-1
Formula Weight

365.25
Molecular Formula

C16H13FNO6P
Purity

>98% (HPLC)
Solubility

——
SMILES

O=P(O)(OC1=C(OC)C=CC(NC(C2=CC=CC(F)=C2)=C3)=C1C3=O)O
Chemical Name

2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin5-yl dihydrogen phosphate